Yoshito Tsushima MD PhD
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine

 

Gadolinium-based contrast agents (GBCAs) play an essential role in MRI, where they significantly enhance lesion detection and characterization. As these agents are administered not for treatment but solely for diagnostic purposes, their safety must always be regarded as the highest priority.


From a clinical perspective, GBCAs are generally considered safe; however, rare but serious adverse reactions, including hypersensitivity reactions and nephrogenic systemic fibrosis (NSF), necessitate continued vigilance. Furthermore, evidence of gadolinium retention in the human body, even in patients with normal renal function, underscores the importance of minimizing unnecessary exposure. Radiologists must therefore ensure that the use of GBCAs is carefully justified and optimized for each individual patient. At the same time, radiographers are the healthcare professionals closest to the patient and are often the first to recognize acute reactions such as anaphylaxis; therefore, they must also be thoroughly familiar with the safe use of contrast agents.


In parallel, the environmental implications of gadolinium use have become an increasing concern. Gadolinium is a rare earth element that is not effectively removed by conventional wastewater treatment processes, leading to its accumulation in aquatic environments. Detectable levels of anthropogenic gadolinium have been reported in rivers and drinking water, raising questions about potential long-term ecological effects.
In this context, reducing the administered dose of GBCAs represents a key strategy that aligns both patient safety and environmental stewardship. Advances in MRI technology enable diagnostic imaging with lower contrast doses. In addition, adherence to appropriate use criteria and avoidance of unnecessary contrast-enhanced studies are essential.
Ultimately, the responsible use of GBCAs requires a balanced approach that integrates clinical necessity, patient safety, and environmental sustainability. Radiology should take a leading role in promoting practices that protect both patients and the environment.

 

I26004416